Odulimomab, CAS 159445-64-4

Product Description: Odulimomab (anti-LFA1) is an anti-LFA-1 monoclonal antibody. Odulimomab inhibits proliferation of T lymphocyte and shows protective effects against ischemia and reperfusion injury. Odulimomab can be used for the research of transplant rejection and immunological disease[1][2].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Martin X, et al. Protective effect of an anti-LFA 1 monoclonal antibody (odulimomab) on renal damage due to ischemia and kidney autotransplantation. Transplant Proc. 2000 Mar;32(2):481./[2]M. Hourmant & J. P. Soulillou. Interest in an anti-LFA-1 monoclonal antibody in the prevention of reperfusion injury in kidney transplantation. Organ Allocation pp 215–223.

CAS Number: 159445-64-4

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Integrin

• Artikelnummer: MEXHY-P99765-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99765-0
• Verpackungseinheit: Get quote
• Mengeneinheit: STK
• Konjugat: Unconjugated